Feedback / Questions
Cu-67 SAR-Bombesin - Clarity Pharma
https://www.prnewswire.com/news-releases/recruitment-opens-for-phase-ii-trial-in-prostate-cancer-with-cu-64-sar-bombesin-in-the-us-301617578.html
Sep 5, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next